Supha Pharmachem has informed that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 to consider and approve Un-Audited Financial Results/Statements (Standalone & Consolidated) of the Company for the Third Quarter and Nine months ended December, 31, 2025.
The above information is a part of company’s filings submitted to BSE.